Spirometry for the diagnosis and management of chronic obstructive pulmonary disease

Respiratory Care

Volumn 54, Issue 8, 2009, Pages 1050-1057

  MacIntyre, Neil R ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY HOSPITAL   (United States)

Author keywords

Chronic obstructive pulmonary disease management; Obstructive airway disease; Perioperative risk assessment; Pulmonary function tests; Screening tests; Spirometry

Indexed keywords

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DISEASE EXACERBATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; OCCULT AIRFLOW OBSTRUCTION; QUALITY OF LIFE; RESPIRATORY THERAPIST; SCREENING TEST; SPIROGRAPHY; SPIROMETRY; SURVIVAL; TOTAL LUNG CAPACITY; VITAL CAPACITY;

FORCED EXPIRATORY VOLUME; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY THERAPY; SPIROMETRY;

EID: 68549126767     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (58)

1. Hutchinson J. On the capacity of the lungs and on the respiratory functions, with a view of establishing a precise and easy method of detecting diseases by the spirometer. Trans Med Soc Lond 1846;29: 137-252.
2. Mead J. Expiratory flow limitation: a physiologist's point of view. Fed Proc 1980;39(10):2771-2775. (Pubitemid 11247330)
3. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, et al; ATS/ERS Task Force. Standardization of spirometry. Eur Respir J 2005;26(2):319-338.
4. Hankinson JL, Odencranz JR, Fedan FB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159(1):179-187. (Pubitemid 29036522)
5. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968. (Pubitemid 41632054)
6. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2008. http://www.goldcopd. com/. Accessed June 10, 2009.
7. Flaherty KR, Martinez FJ. The role of pulmonary function testing in pulmonary fibrosis. Curr Opin Pulm Med 2000;6(5):404-410. (Pubitemid 30637653)
8. Crapo RO. Jensen RL. Standards and interpretive issues in lung function testing. Respir Care 2003;48(8):764-772. (Pubitemid 47377825)
9. Gardner RM, Clausen JL, Epler G, Hankinson JL, Permutt S, Plummer AL. Pulmonary function laboratory personnel qualifications. Am Rev Respir Dis 1986;134:623-624. (Pubitemid 16014431)
10. The National Lung Health Education Program (NLHEP). Strategies in preserving lung health and preventing COPD and associated diseases. Chest 1998;113(2 Suppl):123S-163S.
11. Zielinski J, Bednarek M; Know the Age of Your Lung Study Group. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001;119(3):731-736.
12. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000;117(4):1146-1161. (Pubitemid 30228377)
13. Eaton T, Withy S, Garrett J, Mercer J, Whitlock RM, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999;116(2): 416-423. (Pubitemid 29382127)
14. Hankinson JL. Office spirometry: does poor quality render it impractical? Chest 1999;116(2):276-277.
15. White P, Wong W, Fleming T, Gray B. Primary care spirometry: test quality and the feasibility and usefulness of specialist reporting. Brit J Gen Pract 2007;57(542):701-705. (Pubitemid 47423015)
16. Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood- Baker R. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax 2008; 63(5):408-414.
17. Enright P. Provide GPs with spirometry, not spirometers. Thorax 2008;63(5):387-388. (Pubitemid 351692340)
18. 1/FVC ratio below the fifth percentile, not < 70%. Chest 2007;131:349-355.
19. Collen J, Greenburg D, Holley A, King CS, Hnatiuk O. Discordance in spirometric interpretations using three commonly used reference equations vs national health and nutrition examination study III. Chest 2008;134(5):1009- 1016.
20. Walker PP, Mitchell P, Diamantea F, Warburton CJ, Davies L. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur Respir J 2006;28(5):945-952. (Pubitemid 46331963)
21. Yawn BP, Enright PL, Lemanske RF Jr, Pace W, Wollan P, Boushey H. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest 2007; 132(4):1162-1168. (Pubitemid 47620988)
22. Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest 2006;129(6):1509-1515. (Pubitemid 43894979)
23. Buffels J, Degryse J, Heyman J, Decramer M. Office spirometry significantly improves early detection of COPD in general practice. Chest 2004;125(4):1394-1399. (Pubitemid 38501355)
24. Han MK, Kim MG, Mardon R, Renner P, Sullivan S, Diette GB, Martinez FJ. Spirometry utilization for COPD: how do we measure up? Chest 2007;132(2):403-409.
25. Anthonisen NR, Connett JE, Murray RP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002;166(5):675-679.
26. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irving CG, et al. Guidelines for methacholine and exercise challenge testing- 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161(1):309-329.
27. Lunn WW, Sheller JR. Flow volume loops in the evaluation of upper airway obstruction. Otolaryngol Clin North Am 1995;28(4):721-729.
28. Celli BR. The importance of spirometry in COPD and asthma. Chest 2000;117(2 Suppl):15S-19S.
29. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000;321(7257):355-358. (Pubitemid 30496881)
30. Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowsk M, Regula J, Miszko-Filipczyk G, et al. Smokers with airway obstruction are more likely to quite smoking. Thorax 2006;61(10):869-873. (Pubitemid 44570307)
31. Stratelis G, Mostad S, Jakobsson P, Zetterström O. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scan J Prim Health Care 2006;24(3):133-139. (Pubitemid 44272848)
32. 1 and asbestos exposure. Eur Respir J 1998;11(2):284-290.
33. Buffels J, Degryse J, Decramer J, Heyrman J. Spirometry and smoking cessation advice in general practice: a randomized clinical trial. Respir Med 2006;100(11):2012-2017. (Pubitemid 44490279)
34. Sippel JM, Osborne ML, Bjornson W, Goldberg B, Buist AS. Smoking cessation in primary care clinics. J Gen Int Med 1999;14(11): 670-676.
35. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Int Med 1995;155(18): 1933-1941.
36. Enright P. Does screening for COPD by primary care physicians have the potential to cause more harm than good? Chest 2006;129(4): 833-835.
37. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1(6077):1645-1648. (Pubitemid 8124466)
38. Lin K, Watkins B, Johnsn T, Rodriguez JA, Barton MB. Screening for COPD using spirometry: summary of the evidence for the US Preventive Services Task Force. Ann Int Med 2008;148(7):535-543.
39. Dales RE, Vandemheen KL, Clinch J, Aaron SD. Spirometry in the primary care setting: influence on clinical diagnosis and management of airflow obstruction. Chest 2005;128(4):2443-2447. (Pubitemid 41507592)
40. Lusuardi M, De Benedetto F, Paggiaro P, Sanguinetti CM, Brazzola G, Ferri P, Donner CF. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in asthma and COPD: a comparative evaluation Italian study. Chest 2006;129(4):844-852.
41. Stratelis G, Jakobsson P, Molstad S, Zetterstrom O. Early detection of COPD in primary care: screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract. 2004;54(500):201-206. (Pubitemid 38292015)
42. Castillo D, Guayta R, Giner J, Burgos F, Capdevila C, Soriano JB, et al; FARMAEPOC group. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study. Respir Med 2009;103(6):839-845.
43. Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008;63(5):402-407. (Pubitemid 351692346)
44. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348(21): 2059-2073. (Pubitemid 44080068)
45. Fuso L, Cisternino L, Di Napoli A, Di Cosmo V, Tramaglino LM, Basso S, et al. Role of spirometric and arterial gas data in predicting pulmonary complications after abdominal surgery. Respir Med 2000; 94(12):1171-1176. (Pubitemid 32049243)
46. Qaseem A, Snow V, Fitterman N, Hornbake ER, Lawrence VA, Smetana GW, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 2006;144(8):575-580. (Pubitemid 46768148)
47. McGlone S, Venn A, Walters EH, Wood-Baker R. Physical activity, spirometry and quality-of-life in chronic obstructive pulmonary disease. J Chron Obst Pulm Dis 2006;3(2):83-88. (Pubitemid 43739179)
48. Plankeel JF, McMullen B, MacIntyre NR. Exercise outcomes after pulmonary rehabilitation depend on the initial mechanism of exercise limitation among non-oxygen-dependent COPD patients. Chest 2005;127(1):110-116. (Pubitemid 41724563)
49. de Marco R. What evidence could validate the definition of COPD? Thorax 2008;63(9):756-757.
50. Fan VS, Ramsey SD, Make BJ, Martinez FJ. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. J Chron Obstr Pulm Dis 2007;4(1):29-39.
51. Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005;26(3):414-419. (Pubitemid 41264202)
52. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the first national health and nutrition examination survey follow up study. Thorax 2003;58(5):388-393. (Pubitemid 36560940)
53. Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10(12):2794-2800. (Pubitemid 28052790)
54. Traver GA, Cline MG, Burrows B. Predictions of mortality in COPD: a 15 year follow-up study. Am Rev Respir Dis 1979;119(6):895-902.
55. Kanner RE, Renzetti AD Jr, Stanish WM, Barkham HW Jr, Klauber MR. Predictions of survival in subjects with chronic airflow limitation. Am J Med 1983;74(2):249-255. (Pubitemid 13192181)
56. Kanner RE, Renzetti AD Jr. Predictions of spirometric changes and mortality in the obstructive airway disorders. Chest 1984;85(Suppl): 15S-17S.
57. 1. J Respir Med 2008;102(Suppl 1):S27-S35.
58. Martinez FJ, Han MK, Andrei AC, Wise R, Murray S, Curtis JL, et al; National Emphysema Treatment Trial Research Group. Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med 2008;178(5):491-499.